QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)

Hossein Safizadeh, Zahra Farahmandinia, Simin Soltani nejad, Nasim Pourdamghan, Majid Araste
  • Hossein Safizadeh
    Neurosciences Research Center, Kerman University of Medical Sciences, Iran, Islamic Republic of | hsafizade@kmu.ac.ir
  • Zahra Farahmandinia
    Department of pediatrics, Afzalipour Medicine School, Kerman University of Medical Sciences, Iran, Islamic Republic of
  • Simin Soltani nejad
    Medical Student Research Committee, Kerman University of Medical Sciences, Iran, Islamic Republic of
  • Nasim Pourdamghan
    Kerman University of Medical Sciences,
  • Majid Araste
    Iranian Thalassemia Society,

Abstract

Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia stand among the most severe forms. Due to recent improvements in treatment, patients with thalassemia have longer life expectancies; hence it is of utmost importance to pay careful attention to their quality of life together with life expectancy. This study was conducted to assess the quality of life in patients with thalassemia and also to compare it between thalassemia major and intermedia. In this cross-sectional study, patients who referred for blood transfusion or follow-up visits were evaluated for their quality of life (QOL). Short Form-36 questionnaire was applied to evaluate QOL. In this study, 308 patients with a mean age of 22.95±4.82 years were evaluated. The scores of QOL were regarded as moderate in eight domains under evaluation; the least score was given to General Health (53.05±16.96) whereas the highest score was given to Physical Functioning (67.95±22.68). The QOL in the patients with thalassemia major was better than those with thalassemia intermedia regarding Physical Functioning and Role Limitation Emotional domains. Compared to injecting chelators, patients who received oral chelators showed to have a better QOL considering Social Functioning and Mental Health domain. The patients under study didn’t have a satisfying QOL ;  the QOL of patients with thalassemia major was better than that of patients with  thalassemia intermedia in only 2 domains of sf-36(Physical Functioning & Role limitation-Emotional). It is then essential that experts pay proper attention to improve QOL among patients.

Keywords

Thalassemia; Quality of Life; Iran

Full Text:

PDF
HTML
Submitted: 2014-06-13 09:32:03
Published: 2012-10-03 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
241

Views:
PDF
112
HTML
1787

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2016 Mediterranean Journal of Hematology and Infectious Diseases

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

The Mediterranean Journal of Hematology and Infectious Diseases [eISSN 2035-3006] is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.
 
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185